GTG developing a genetic test in the fight against COVID-19
Finfeed
Archived
May 22, 2020
Genetic Technologies (ASX: GTG | NASDAQ: GENE) is fast-tracking development of a genetic test that will determine if people are at a high risk of contracting COVID-19.
